Kansas Patent of the Month – March 2023
CritiTech Inc, experts in the drug development life-cycle, have been granted a patent for their new method of treating cancer which combines local and systemic therapies using antineoplastic particles and an immunotherapeutic agent.
The key to this invention is the use of antineoplastic particles, which are chemotherapeutic particles that can be topically applied directly to the tumor site. The particles are taxane particles between the size of 0.1 microns to 5 microns. Taxane particles include a range of particles such as paclitaxel, docetaxel, and cabazitaxel. Once the antineoplastic particles are topically applied to the tumor site, an immunotherapeutic agent is administered and activated to identify and attack cancer cells.
This method of treatment is highly adaptable, with different delivery methods that can be used depending on the location of the cancer. For instance, pulmonary administration of the antineoplastic particles through nebulization is effective for lung cancer patients with obstructive or restrictive lung disease. Intratumoral injection of the particles is used for solid tumors, such as sarcomas, carcinomas, lymphomas, and head and neck tumors, among others. Finally, intraperitoneal injection of the particles is used for ovarian tumors.
CritiTech’s innovative approach to cancer treatment is a reminder of how science and technology can make a significant impact on the world. It is encouraging to see inventors and scientists working hard to create new ways to treat cancer and other diseases. Who knows what the future holds for cancer treatment, but one thing is for sure: we are on the right path.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
